Over the last couple of months, C2C’s Maternal Health Program has grown in popularity even more--we now have a 1-2 month waiting list for two of the three clinics that offer these services!
Even though the program is already popular, we are always trying to improve its quality and efficiency. Thanks to the support of GlobalGiving donors, we are currently innovating new ways to increase patient throughput and reduce waiting times (especially in the laboratory). One of the first changes we made was to provide our laboratories with a second microscope. From the 25 women we enroll for the day, eight of them are new patients, and the rest are for follow-ups. The newly-admitted patients have ten laboratory tests, which take the most time. The second microscope will reduce the time the laboratory technicians take to deliver critical results. We are also looking at soliciting the expert advice of an OB-GYN specializing in global health to see how we can modify the maternal health protocol and see more patients.
Thanks to the generosity of our GlobalGiving community, since the beginning of 2021, we have had 2,048 antenatal care visits across three clinics! Of those, we have had more than 385 women come for at least four antenatal visits. In addition, we have administered more than 1,000 Diphtheria vaccine shots to maximize the maternal antibody response and passive antibody transfer in the newborn. We have also conducted more than 942 ultrasound tests.
Furthermore, our community health team is working hard organizing postnatal visits to check on the health status of the new mothers and babies. The team is also encouraging mothers to come to the clinic and get their children vaccinated and do a follow-up consultation with our doctors.
All this cannot be done without the support and generosity of the general population. Still, the Maternal Health Program is a highly in-demand service at all our clinics (currently it is in three of our seven clinics). We are hoping to be able to expand it to the rest of our network of clinics in the near future.